EUVIMEDEUVIMED entdecken
Crossref

Contraceptive use in patients with gender dysphoria who were assigned female at birth receiving care at a specialty gender-affirming clinic

Zoe Kasten, Sean Lujan, Bernadette Jakeman, Alexandra Herman, Molly McClain, Ashley Winters, Alexander J Bos, Kelsea Gallegos Aragon

Journal of the American Pharmacists Association · 2024-01 · 64 (1) · 273-277

DOI: 10.1016/j.japh.2023.08.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Pharmacists Association, 2024-01. Verfasst von Zoe Kasten und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Contraceptive Agents, Gender Dysphoria. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The Centers for Disease Control and Prevention (CDC) recommend that all patients, regardless of gender identity or sexual orientation, should be offered family planning and contraceptive options without assumptions of sexual behaviors and pregnancy risk. Current research on family planning services for lesbian, gay, bisexual, transgender, and queer or questioning patients is limited, but patients who are sexual or gender minorities are at increased risk for unintended pregnancy. OBJECTIVES: The objective of this study was to describe contraceptive use in patients assigned female at birth with gender dysphoria at a gender-affirming primary care clinic. METHODS: A retrospective descriptive study was conducted. Patients were included if they were 18 to 44 years old, received care at University of New Mexico Truman Health Services in 2019, were diagnosed with gender dysphoria, and were assigned female at birth. Patients were excluded if they had never developed female reproductive organs. Data were collected from the electronic medical records. Potential differences in contraceptive use based on demographic characteristics, having a family planning discussion, and having a contraceptive use discussion were analyzed using chi-square analyses. Potential predictors of contraceptive use were identified using exploratory forward conditional logistic regression and univariate logistic regression analyses. RESULTS: A total of 163 patients were included; average age was 26.6 years; 71% identified as male, 5% identified as masculine, and 25% identified as nonbinary. Most patients (92%) were prescribed masculinizing therapy (testosterone). Forty-five (28%) patients had documented contraception use; the most common form was permanent contraception (76%). Most patients (68%) did not have any documented contraindications to contraception based on CDC US Medical Eligibility Criteria for contraceptive use. Of 113 patients with a documented sexual orientation, 45 patients (40%) reported having sex with persons who have a penis; only 13 (29%) of those patients had a documented form of contraception. Family planning discussions were documented for 82% of patients. Family planning discussions that specifically addressed contraception were documented in only 49% of patients. However, the odds of a patient having a documented use of contraception was 9.26 times higher when family planning discussions specifically addressed contraception. CONCLUSION: Documented contraception use was low in people assigned female at birth of childbearing age receiving care at a gender-affirming clinic. Due to increased risks of unintended pregnancy in this population and the teratogenic nature of testosterone, family planning discussion should also include discussions related to contraception, as this was associated with increased contraception use. Additional research is needed to address potential barriers to contraception use in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Contraceptive AgentsGender DysphoriaPregnancyHumansFemaleMaleAdultAdolescentYoung AdultRetrospective StudiesGender IdentityContraceptionTestosterone

Substanzen

Contraceptive AgentsTestosterone

Zitieren

APA

Kasten, Z., Lujan, S., Jakeman, B., Herman, A., McClain, M., Winters, A., Bos, A. J., & Aragon, K. G. (2024). Contraceptive use in patients with gender dysphoria who were assigned female at birth receiving care at a specialty gender-affirming clinic. Journal of the American Pharmacists Association, 64(1), 273-277. https://doi.org/10.1016/j.japh.2023.08.004

Vancouver

Kasten Z, Lujan S, Jakeman B, Herman A, McClain M, Winters A, et al. Contraceptive use in patients with gender dysphoria who were assigned female at birth receiving care at a specialty gender-affirming clinic. Journal of the American Pharmacists Association. 2024;64(1):273-277. doi:10.1016/j.japh.2023.08.004

BibTeX
@article{Kasten2024,
  author = {Kasten, Zoe and Lujan, Sean and Jakeman, Bernadette and Herman, Alexandra and McClain, Molly and Winters, Ashley and Bos, Alexander J and Aragon, Kelsea Gallegos},
  title = {Contraceptive use in patients with gender dysphoria who were assigned female at birth receiving care at a specialty gender-affirming clinic},
  journal = {Journal of the American Pharmacists Association},
  year = {2024},
  volume = {64},
  number = {1},
  pages = {273--277},
  doi = {10.1016/j.japh.2023.08.004}
}
Kostenlos starten →